跳至主要内容
临床试验/NCT03268733
NCT03268733Unknown1 期

The Clinical and Biochemical Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome (PCOS)

University of Khartoum1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
90
试验地点
1
主要终点
Ovulatory pattern improvements

研究概览

简要总结

An open clinical trial

详细描述

The patients with PCOS will be recruited to receive folic acid (45 patients) and equal number will receive no folic acid

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who will visit this centre suffering from PCOS-related subfertility will be invited to be enrolled to this study if met the Rotterdam criteria for the diagnosis of PCOS

排除标准

  • The patients whom will be excluded from the study are those comorbid with hyperprolactinemia, congenital adrenal hyperplasia, diabetes mellitus, significant cardiovascular problems, thyroid dysfunctions, unresolved medical conditions, or using medications suspected to affect reproductive or metabolic functions within two months of the study entry.

研究组 & 干预措施

Treatment group

Experimental

45 PCOS patients will receive 5 mg folic acid

干预措施: Folic Acid (Drug)

结局指标

主要结局

Ovulatory pattern improvements

时间窗: 3 months

Ovulatory pattern will be assessed based on the history of the PCOS patients, the patients whom were having baseline oligomenorrhea or amenorrhea will be re-assessed for resuming regular cycles defined as periods lasting 22 - 35 days. this pattern improvement will be compared in the treatment group and control group using questionnaire

Clinical signs of hyperandrogenemia

时间窗: 3 months

Hirsutism will be used as a sign of hyperandrogenemia, Patients will be provided with modified Ferriman -Gallwey (mFG) images to self-rate hair growth in each of the 9 body areas (upper lip, chin, chest, upper and lower back, upper and lower abdomen, thighs, and upper arms). For each site, a score on a scale of 0 to 4 was recorded. A total score of 8 or greater is defined as clinical evidence of hirsutism; scores from 8 to 15 are considered mild hirsutism; scores from16 to 25 are considered moderate; and scores from 26 to 36 are considered severe hirsutism. The baseline and after 3 months hirsutism compared in the treatment group and control group

pregnancy rates

时间窗: 3 months

Pregnancy rates will be compared in the treatment group and control group

次要结局

  • Plasma level of insulin(3 months)
  • Plasma level of testosterone(3 months)
  • Plasma level of follicle-stimulating hormone (FSH)(3 months)
  • Plasma level of luteinizing hormone (LH)(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Hassan Alnazeer

Clinical Pharmacist

University of Khartoum

研究点 (1)

Loading locations...

相似试验